US Stock MarketDetailed Quotes
RMD ResMed
- 218.060
- +34.640+18.89%
Close Apr 26 16:00 ET
- 218.830
- +0.770+0.35%
Post 19:58 ET
32.07BMarket Cap33.55P/E (TTM)
218.380High201.860Low4.33MVolume203.020Open183.420Pre Close926.56MTurnover2.97%Turnover Ratio35.81P/E (Static)147.09MShares237.63652wk High6.93P/B31.76BFloat Cap131.48452wk Low1.88Dividend TTM145.65MShs Float294.870Historical High0.86%Div YieldTTM9.01%Amplitude0.870Historical Low213.943Avg Price1Lot Size
ResMed Stock Forum
Sign in to post a comment
ColumnsGoogle: Wake Up and Smell the Dividends | Moooovers
Morning mooers! It is Finally Friday, April 26th, the market is souring on Mag Seven earnings, even though Personal Consumption Expendetures rose in March.
My name is Kevin Travers, and the beautiful sounds of heavy construction digging foundations for apartments in Jersey City wake me up every morning: the economy is clearly growing.
Here are the morning moovers today:
MOOVERS
The biggest news on the street is $Alphabet-Cearnings that beat and ...
My name is Kevin Travers, and the beautiful sounds of heavy construction digging foundations for apartments in Jersey City wake me up every morning: the economy is clearly growing.
Here are the morning moovers today:
MOOVERS
The biggest news on the street is $Alphabet-Cearnings that beat and ...
11
1
$ResMed(RMD.US$ drop so much，what happened？
Significant insider selling at ResMed, especially by the Founder, and no insider purchases in the past year may suggest insiders believe shares are overpriced. Despite high insider ownership, the selling warrants caution.
$ResMed(RMD.US$ why drop？
ResMed's impressive performance is due to reinvesting a significant portion of its profits at a high rate of return, leading to substantial earnings growth. Analysts forecast similar growth rates to continue.
ResMed's CEO, Mick Farrell, opines that the market overreacted to the impact of weight-loss drugs on sleep apnea. He suggests that these drugs will complement treatments like ResMed's CPAP systems and that sleep apnea patients using GLP-1s are more motivated to improve their health.
1
ResMed's high ROCE and ability to reinvest capital at profitable rates suggest potential multi-bagger status. Further research is recommended to understand the current share price value.
1
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Kevin TraversOP : Yesterday, User @gab3x said robotaxis definitely will be the next thing in our lives whether we love it or not.just like AI will continue to grow. So, if Tesla is involved, it will definitely benefit from it.